{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:28:57Z","timestamp":1793888937956,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["217637"],"award-info":[{"award-number":["217637"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["175780"],"award-info":[{"award-number":["175780"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In major depressive disorder (MDD), main clinical features include insomnia and increased daytime sleepiness. However, specific treatment options to promote sleep in MDD are limited. Gamma-hydroxybutyrate (GHB, administered as sodium oxybate) is a GHB\/GABA\n                    <jats:sub>B<\/jats:sub>\n                    receptor agonist used clinically in narcolepsy, where it promotes restorative slow-wave sleep (SWS) while reducing next-day sleepiness. Hence, we performed a randomized, placebo- and active comparator-controlled, double-blind, crossover trial to investigate the sleep-promoting properties of GHB in individuals with MDD. Outpatients aged 20\u201365 years fulfilling the DSM-5 criteria for MDD were enrolled. A single nocturnal dose of GHB (50\u2009mg\/kg) was compared with a single evening dose of the clinical competitor trazodone (1.5\u2009mg\/kg) and placebo. Of 29 randomized patients, 23 received at least one intervention and were included in the analysis. Primary outcomes were nocturnal slow wave sleep ([SWS] assessed by polysomnography), next-day vigilance (median response time and number of lapses on the psychomotor vigilance test [PVT]), next-day working memory (median speed and accuracy on an N-back task), and next-day plasma brain-derived neurotrophic factor (BDNF) levels. GHB robustly prolonged SWS compared to both trazodone and placebo. GHB also prolonged total sleep time and enhanced sleep efficiency, while reducing sleep stages N1, N2, and wake-after-sleep-onset. While the median response time on the next-day PVT was unaffected, GHB reduced the number of lapses compared to trazodone and placebo. No effects on next-day working memory performance and BDNF levels were observed. No serious adverse events occurred. Overall, a single nocturnal dose of GHB effectively promotes SWS and shows more favorable effects on next-day vigilance than trazodone and placebo. Future studies should investigate GHB in clinical settings, including repeated administration.\n                  <\/jats:p>","DOI":"10.1038\/s41386-025-02104-4","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:28:17Z","timestamp":1744630097000},"page":"1237-1244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gamma-hydroxybutyrate to promote slow-wave sleep in major depressive disorder: a randomized crossover trial"],"prefix":"10.1038","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3787-6706","authenticated-orcid":false,"given":"Francesco","family":"Bavato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6332-5712","authenticated-orcid":false,"given":"Laura K.","family":"Schnider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario A.","family":"Dornbierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia R.","family":"Di Floriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-2927","authenticated-orcid":false,"given":"Benjamin","family":"Stucky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Friedli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Janki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7933-2865","authenticated-orcid":false,"given":"Boris B.","family":"Quednow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0887-9403","authenticated-orcid":false,"given":"Hans-Peter","family":"Landolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-0859","authenticated-orcid":false,"given":"Oliver G.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"2104_CR1","unstructured":"World Health Organization. Depression and other common mental disorders: global health estimates. World Health Organization. 2017."},{"key":"2104_CR2","doi-asserted-by":"crossref","unstructured":"Nutt D, Wilson S, Paterson L. Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 2008;10:329\u201336.","DOI":"10.31887\/DCNS.2008.10.3\/dnutt"},{"key":"2104_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S1389-9457(08)70010-8","volume":"9","author":"RM Benca","year":"2008","unstructured":"Benca RM, Peterson MJ. Insomnia and depression. Sleep Med. 2008;9:S3\u2013S9.","journal-title":"Sleep Med"},{"key":"2104_CR4","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.biopsych.2011.07.016","volume":"70","author":"V Pillai","year":"2011","unstructured":"Pillai V, Kalmbach DA, Ciesla JA. A meta-analysis of electroencephalographic sleep in depression: evidence for genetic biomarkers. Biol Psychiatry. 2011;70:912\u201319.","journal-title":"Biol Psychiatry"},{"key":"2104_CR5","first-page":"189","volume":"4","author":"A Borb\u00e9ly","year":"1985","unstructured":"Borb\u00e9ly A, Mattmann P, Loepfe M, Strauch I, Lehmann D. Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol. 1985;4:189\u201394.","journal-title":"Hum Neurobiol"},{"key":"2104_CR6","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.2146\/ajhp160381","volume":"75","author":"JD Picton","year":"2018","unstructured":"Picton JD, Marino AB, Nealy KL. Benzodiazepine use and cognitive decline in the elderly. Am J Health Syst Pharm. 2018;75:e6\u2013e12.","journal-title":"Am J Health Syst Pharm"},{"key":"2104_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/0269881111421975","volume":"26","author":"OG Bosch","year":"2012","unstructured":"Bosch OG, Quednow BB, Seifritz E, Wetter TC. Reconsidering GHB: orphan drug or new model antidepressant? J Psychopharmacol. 2012;26:618\u201328.","journal-title":"J Psychopharmacol"},{"key":"2104_CR8","doi-asserted-by":"crossref","unstructured":"Bavato F, Schnider LK, Dornbierer DA, Seifritz E. Oral sodium oxybate does not alter plasma kisspeptin levels in healthy male volunteers. J Psychopharmacol. 2023;37:942\u201344.","DOI":"10.1177\/02698811231185097"},{"key":"2104_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","volume":"29","author":"J Black","year":"2006","unstructured":"Black J, Houghton WC. Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep. 2006;29:939\u201346.","journal-title":"Sleep"},{"key":"2104_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/jamaneurol.2017.3171","volume":"75","author":"F Buchele","year":"2018","unstructured":"Buchele F, Hackius M, Schreglmann SR, Omlor W, Werth E, Maric A, et al. Sodium oxybate for excessive daytime sleepiness and sleep disturbance in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2018;75:114\u201318.","journal-title":"JAMA Neurol"},{"key":"2104_CR11","first-page":"1070","volume":"30","author":"MB Scharf","year":"2003","unstructured":"Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol. 2003;30:1070\u20134.","journal-title":"J Rheumatol"},{"key":"2104_CR12","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/s41386-019-0382-z","volume":"44","author":"DA Dornbierer","year":"2019","unstructured":"Dornbierer DA, Baur DM, Stucky B, Quednow BB, Kraemer T, Seifritz E, et al. Neurophysiological signature of gamma-hydroxybutyrate augmented sleep in male healthy volunteers may reflect biomimetic sleep enhancement: a randomized controlled trial. Neuropsychopharmacology. 2019;44:1985\u201393.","journal-title":"Neuropsychopharmacology"},{"key":"2104_CR13","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s40263-012-0010-5","volume":"26","author":"A Fagiolini","year":"2012","unstructured":"Fagiolini A, Comandini A, Dell\u2019Osso MC, Kasper S. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 2012;26:1033\u201349.","journal-title":"CNS Drugs"},{"key":"2104_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1469-8986.1979.tb02991.x","volume":"16","author":"I Feinberg","year":"1979","unstructured":"Feinberg I, Floyd TC. Systematic trends across the night in human sleep cycles. Psychophysiology. 1979;16:283\u201391.","journal-title":"Psychophysiology"},{"key":"2104_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2021.101318","volume":"8","author":"C Blume","year":"2021","unstructured":"Blume C, Cajochen C. SleepCycles\u2019 package for R-A free software tool for the detection of sleep cycles from sleep staging. MethodsX. 2021;8:101318.","journal-title":"MethodsX"},{"key":"2104_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneumeth.2018.08.014","volume":"316","author":"K Lacourse","year":"2019","unstructured":"Lacourse K, Delfrate J, Beaudry J, Peppard P, Warby SC. A sleep spindle detection algorithm that emulates human expert spindle scoring. J Neurosci Methods. 2019;316:3\u201311.","journal-title":"J Neurosci Methods"},{"key":"2104_CR17","doi-asserted-by":"crossref","unstructured":"Fernandez LM, L\u00fcthi A. Sleep spindles: mechanisms and functions. Physiol Rev. 2020;100:805\u201368.","DOI":"10.1152\/physrev.00042.2018"},{"key":"2104_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1196\/annals.1417.002","volume":"1129","author":"J Lim","year":"2008","unstructured":"Lim J, Dinges DF. Sleep deprivation and vigilant attention. Ann N. Y Acad Sci. 2008;1129:305\u201322.","journal-title":"Ann N. Y Acad Sci"},{"key":"2104_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110232","volume":"109","author":"DM Baur","year":"2021","unstructured":"Baur DM, Lange D, Elmenhorst E-M, Elmenhorst D, Bauer A, Aeschbach D, et al. Coffee effectively attenuates impaired attention in ADORA2A C\/C-allele carriers during chronic sleep restriction. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;109:110232.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2104_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1017\/S1461145712000545","volume":"16","author":"WC Duncan","year":"2013","unstructured":"Duncan WC, Sarasso S, Ferrarelli F, Selter J, Riedner BA, Hejazi NS, et al. Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. Int J Neuropsychopharmacol. 2013;16:301\u201311.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2104_CR21","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.5664\/jcsm.4042","volume":"10","author":"J Thomann","year":"2014","unstructured":"Thomann J, Baumann CR, Landolt H-P, Werth E. Psychomotor vigilance task demonstrates impaired vigilance in disorders with excessive daytime sleepiness. J Clin Sleep Med. 2014;10:1019\u201324.","journal-title":"J Clin Sleep Med"},{"key":"2104_CR22","doi-asserted-by":"publisher","first-page":"zpac045","DOI":"10.1093\/sleepadvances\/zpac045","volume":"4","author":"KA Honn","year":"2023","unstructured":"Honn KA, Van Dongen HPA. Paradoxical effects from stimulus density manipulation provide new insight into the impact of sleep deprivation on PVT performance. Sleep Adv. 2023;4:zpac045.","journal-title":"Sleep Adv"},{"key":"2104_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds III, CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213.","journal-title":"Psychiatry Res"},{"key":"2104_CR24","doi-asserted-by":"crossref","unstructured":"Frohlich J, Mediano PAM, Bavato F, Gharabaghi A. Paradoxical pharmacological dissociations result from drugs that enhance delta oscillations but preserve consciousness. Commun Biol. 2023;6:654.","DOI":"10.1038\/s42003-023-04988-8"},{"key":"2104_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.smrv.2018.01.008","volume":"41","author":"D L\u00e9ger","year":"2018","unstructured":"L\u00e9ger D, Debellemaniere E, Rabat A, Bayon V, Benchenane K, Chennaoui M. Slow-wave sleep: from the cell to the clinic. Sleep Med Rev. 2018;41:113\u201332.","journal-title":"Sleep Med Rev"},{"key":"2104_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.31887\/DCNS.2006.8.2\/mthase","volume":"8","author":"ME Thase","year":"2006","unstructured":"Thase ME. Depression and sleep: pathophysiology and treatment. Dialogues Clin Neurosci. 2006;8:217\u201326.","journal-title":"Dialogues Clin Neurosci"},{"key":"2104_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jagp.2023.03.009","volume":"31","author":"RL Rios","year":"2023","unstructured":"Rios RL, Kafashan M, Hyche O, Lenard E, Lucey BP, Lenze EJ, et al. Targeting slow wave sleep deficiency in late-life depression: a case series with propofol. Am J Geriatr Psychiatry. 2023;31:643\u201352.","journal-title":"Am J Geriatr Psychiatry"},{"key":"2104_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0006-3223(95)00139-5","volume":"39","author":"CL Ehlers","year":"1996","unstructured":"Ehlers CL, Havstad JW, Kupfer DJ. Estimation of the time course of slow-wave sleep over the night in depressed patients: effects of clomipramine and clinical response. Biol Psychiatry. 1996;39:171\u201381.","journal-title":"Biol Psychiatry"},{"key":"2104_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1017\/S1461145712000545","volume":"16","author":"WC Duncan Jr","year":"2012","unstructured":"Duncan WC Jr, Sarasso S, Ferrarelli F, Selter J, Riedner BA, Hejazi NS, et al. Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. Int J Neuropsychopharmacol. 2012;16:301\u201311.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2104_CR30","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/sj.npp.1300923","volume":"31","author":"DA Schmid","year":"2006","unstructured":"Schmid DA, Wichniak A, Uhr M, Ising M, Brunner H, Held K, et al. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology. 2006;31:832\u201344.","journal-title":"Neuropsychopharmacology"},{"key":"2104_CR31","doi-asserted-by":"crossref","unstructured":"Dornbierer DA, Z\u00f6lch N, Baur DM, Hock A, Stucky B, Quednow BB, et al. Nocturnal sodium oxybate increases the anterior cingulate cortex magnetic resonance glutamate signal upon awakening. J Sleep Res. 2023:32:e13866.","DOI":"10.1111\/jsr.13866"},{"key":"2104_CR32","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1093\/cercor\/bhad097","volume":"33","author":"F Bavato","year":"2023","unstructured":"Bavato F, Esposito F, Dornbierer DA, Z\u00f6lch N, Quednow BB, Staempfli P, et al. Subacute changes in brain functional network connectivity after nocturnal sodium oxybate intake are associated with anterior cingulate GABA. Cereb Cortex. 2023;33:8046\u201355.","journal-title":"Cereb Cortex"},{"key":"2104_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/sleep\/14.5.399","volume":"14","author":"MH Kryger","year":"1991","unstructured":"Kryger MH, Steljes D, Pouliot Z, Neufeld H, Odynski T. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem. Sleep. 1991;14:399\u2013407.","journal-title":"Sleep"},{"key":"2104_CR34","doi-asserted-by":"crossref","unstructured":"Calder AE, Hase A, Hasler G. Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis. Mol Psychiatry. 2025;30:763\u201376.","DOI":"10.1038\/s41380-024-02830-z"},{"key":"2104_CR35","doi-asserted-by":"crossref","unstructured":"Kushida CA, Shapiro CM, Roth T, Thorpy MJ, Corser BC, Ajayi AO, et al. Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy. Sleep. 2022;45:zsab200.","DOI":"10.1093\/sleep\/zsab200"},{"key":"2104_CR36","doi-asserted-by":"crossref","unstructured":"Nishida M, Nakashima Y, Nishikawa T. Slow sleep spindle and procedural memory consolidation in patients with major depressive disorder. Nat Sci Sleep. 2016;8:63\u201372.","DOI":"10.2147\/NSS.S100337"},{"key":"2104_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsac193","volume":"45","author":"A Mayeli","year":"2022","unstructured":"Mayeli A, Wilson JD, Donati FL, LaGoy AD, Ferrarelli F. Sleep spindle alterations relate to working memory deficits in individuals at clinical high-risk for psychosis. Sleep. 2022;45:zsac193.","journal-title":"Sleep"},{"key":"2104_CR38","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3233\/JAD-181145","volume":"67","author":"AL La","year":"2019","unstructured":"La AL, Walsh CM, Neylan TC, Vossel KA, Yaffe K, Krystal AD, et al. Long-term trazodone use and cognition: a potential therapeutic role for slow-wave sleep enhancers. J Alzheimer\u2019s Dis. 2019;67:911\u201321.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2104_CR39","doi-asserted-by":"crossref","unstructured":"Bavato F. \u03b3-Hydroxybutyric acid: a GABAB\/GHB receptor agonist with a unique neuropharmacological and therapeutic profile. In: Colombo G, editor. GABAB receptor. Cham: Springer International Publishing; 2024. p. 285-303.","DOI":"10.1007\/978-3-031-67148-7_13"},{"key":"2104_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0376-8716(00)00191-5","volume":"63","author":"KL Nicholson","year":"2001","unstructured":"Nicholson KL, Balster RL. GHB: a new and novel drug of abuse. Drug Alcohol Depend. 2001;63:1\u201322.","journal-title":"Drug Alcohol Depend"},{"key":"2104_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coph.2005.10.001","volume":"6","author":"V Crunelli","year":"2006","unstructured":"Crunelli V, Emri Z, Leresche N. Unravelling the brain targets of \u03b3-hydroxybutyric acid. Curr Opin Pharmacol. 2006;6:44\u201352.","journal-title":"Curr Opin Pharmacol"},{"key":"2104_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5664\/jcsm.27549","volume":"5","author":"YG Wang","year":"2009","unstructured":"Wang YG, Swick TJ, Carter LP, Thorpy MJ, Benowitz NL. Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion. J Clin Sleep Med. 2009;5:365\u201371.","journal-title":"J Clin Sleep Med"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02104-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02104-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02104-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:01:50Z","timestamp":1750060910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02104-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2104"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02104-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.02.24314769","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}